These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

592 related items for PubMed ID: 18646811

  • 1. Small-angle X-ray scattering studies on structures of an estrogen-related receptor alpha ligand binding domain and its complexes with ligands and coactivators.
    Jin KS, Park JK, Yoon J, Rho Y, Kim JH, Kim EE, Ree M.
    J Phys Chem B; 2008 Aug 14; 112(32):9603-12. PubMed ID: 18646811
    [Abstract] [Full Text] [Related]

  • 2. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
    Egea PF, Rochel N, Birck C, Vachette P, Timmins PA, Moras D.
    J Mol Biol; 2001 Mar 23; 307(2):557-76. PubMed ID: 11254382
    [Abstract] [Full Text] [Related]

  • 3. Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function.
    Nascimento AS, Dias SM, Nunes FM, Aparício R, Ambrosio AL, Bleicher L, Figueira AC, Santos MA, de Oliveira Neto M, Fischer H, Togashi M, Craievich AF, Garratt RC, Baxter JD, Webb P, Polikarpov I.
    J Mol Biol; 2006 Jul 14; 360(3):586-98. PubMed ID: 16781732
    [Abstract] [Full Text] [Related]

  • 4. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma.
    Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, Rosenfeld MG, Willson TM, Glass CK, Milburn MV.
    Nature; 1998 Sep 10; 395(6698):137-43. PubMed ID: 9744270
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide.
    Vanhooke JL, Benning MM, Bauer CB, Pike JW, DeLuca HF.
    Biochemistry; 2004 Apr 13; 43(14):4101-10. PubMed ID: 15065852
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Exploring the binding site structure of the PPAR gamma ligand-binding domain by computational solvent mapping.
    Sheu SH, Kaya T, Waxman DJ, Vajda S.
    Biochemistry; 2005 Feb 01; 44(4):1193-209. PubMed ID: 15667213
    [Abstract] [Full Text] [Related]

  • 10. Three-dimensional model of the ligand binding domain of the nuclear receptor for 1alpha,25-dihydroxy-vitamin D(3).
    Norman AW, Adams D, Collins ED, Okamura WH, Fletterick RJ.
    J Cell Biochem; 1999 Sep 01; 74(3):323-33. PubMed ID: 10412035
    [Abstract] [Full Text] [Related]

  • 11. Expression, purification, and initial structural characterization of rat orphan nuclear receptor NOR-1 LBD domain.
    Razzera G, Vernal J, Portugal RV, Calgaro MR, Fernandez P, Zakin MM, Polikarpov I, Terenzi H.
    Protein Expr Purif; 2004 Oct 01; 37(2):443-9. PubMed ID: 15358368
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism.
    Shiau AK, Barstad D, Radek JT, Meyers MJ, Nettles KW, Katzenellenbogen BS, Katzenellenbogen JA, Agard DA, Greene GL.
    Nat Struct Biol; 2002 May 01; 9(5):359-64. PubMed ID: 11953755
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Solution X-ray scattering reveals a novel structure of calmodulin complexed with a binding domain peptide from the HIV-1 matrix protein p17.
    Izumi Y, Watanabe H, Watanabe N, Aoyama A, Jinbo Y, Hayashi N.
    Biochemistry; 2008 Jul 08; 47(27):7158-66. PubMed ID: 18553937
    [Abstract] [Full Text] [Related]

  • 16. RARbeta ligand-binding domain bound to an SRC-1 co-activator peptide: purification, crystallization and preliminary X-ray diffraction analysis.
    Kammerer S, Germain P, Flaig R, Peluso-Iltis C, Mitschler A, Rochel N, Gronemeyer H, Moras D.
    Acta Crystallogr D Biol Crystallogr; 2004 Nov 08; 60(Pt 11):2048-50. PubMed ID: 15502323
    [Abstract] [Full Text] [Related]

  • 17. Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity.
    Solomon IH, Hager JM, Safi R, McDonnell DP, Redinbo MR, Ortlund EA.
    J Mol Biol; 2005 Dec 16; 354(5):1091-102. PubMed ID: 16289203
    [Abstract] [Full Text] [Related]

  • 18. Molecular dynamics simulation of the ligand binding domain of farnesoid X receptor. Insights into helix-12 stability and coactivator peptide stabilization in response to agonist binding.
    Costantino G, Entrena-Guadix A, Macchiarulo A, Gioiello A, Pellicciari R.
    J Med Chem; 2005 May 05; 48(9):3251-9. PubMed ID: 15857131
    [Abstract] [Full Text] [Related]

  • 19. Rational discovery of a novel interface for a coactivator in the peroxisome proliferator-activated receptor gamma: theoretical implications of impairment in type 2 diabetes mellitus.
    Shiraki T, Kodama TS, Jingami H, Kamiya N.
    Proteins; 2005 Feb 01; 58(2):418-25. PubMed ID: 15558556
    [Abstract] [Full Text] [Related]

  • 20. Ab initio quantum mechanical study of the binding energies of human estrogen receptor alpha with its ligands: an application of fragment molecular orbital method.
    Fukuzawa K, Kitaura K, Uebayasi M, Nakata K, Kaminuma T, Nakano T.
    J Comput Chem; 2005 Jan 15; 26(1):1-10. PubMed ID: 15521089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.